Bionime Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 412.588 million compared to TWD 359.411 million a year ago. Operating income was TWD 4.388 million compared to operating loss of TWD 26.647 million a year ago. Net income was TWD 13.239 million compared to net loss of TWD 14.852 million a year ago. Basic earnings per share was TWD 0.22 compared to basic loss per share of TWD 0.26 a year ago. For the half year, sales was TWD 876.386 million compared to TWD 712.817 million a year ago. Operating income was TWD 14.317 million compared to operating loss of TWD 35.426 million a year ago. Net income was TWD 25.166 million compared to net loss of TWD 23.104 million a year ago. Basic earnings per share was TWD 0.42 compared to basic loss per share of TWD 0.39 a year ago. Diluted earnings per share was TWD 0.41 compared to diluted loss per share of TWD 0.39 a year ago.